45
Chugai
4519.T·TSETokyo JPFounded 19257,800 employees
Large CappharmaPublicOncologyHematologyImmunology
Platform: Recycling Ab
Market Cap
$55B
All Drugs
10
Clinical Trials
19
Failed / Terminated
4
FDA Approved
1
Stock Price & Catalysts (4519.T)
Loading 4519.T stock data...
Drug Pipeline (10 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Tirainavolisib | 451-9710 | Approved | 4 | DLL3 | PBC | ||
| Zenotinib | 451-1882 | Phase 2/3 | 1 | PD-L1 | PNHMDS | ||
| 451-3882 | 451-3882 | Phase 1 | 2 | FGFR | Breast Ca | ||
| Sovaderotide | 451-1951 | Phase 2/3 | 2 | Menin | SCLCAsthma | ||
| 451-5171 | 451-5171 | Preclinical | 1 | KRASG12D | GISTCLL | ||
| 451-2703 | 451-2703 | Phase 1 | 1 | LAG-3 | Crohn'sHNSCC | ||
| Elraderotide | 451-8658 | Phase 1/2 | 1 | Tau | AngelmanParkinson's | ||
| Sovaglumide | 451-9013 | Phase 3 | 4 | PCSK9 | OCDThymoma | ||
| 451-4848 | 451-4848 | Preclinical | 1 | TIM-3 | NBAML | ||
| Ribonesiran | 451-7780 | Phase 1/2 | 2 | IL-23 | MDDGastric Ca |
SEC Filings & Financial Documents
SEC filings are not available for TSE-listed companies.
Chugai trades on TSE (JP). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (17)